Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1354376

registered interest
date	09/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether members of the public who received doses of Astra Zeneca 4120Z001, 4120Z002, 4120Z003 will be entitled to receive a third dose of a vaccination recognised by the European Medicines Agency.
tabling member constituency	North Durham
tabling member printed	Mr Kevan Jones
uin	45808
answer	answer is ministerial correction date of answer 14/09/2021 answer text <p>Members of the public will not be entitled to receive a third dose of a COVID-19 vaccination on the basis of having received doses of AstraZeneca with batch numbers 4120Z001, 4120Z002, 4120Z003. All AstraZeneca vaccine doses administered in the United Kingdom are the same COVID-19 vaccine and have been authorised for use under Regulation 174, having met the strict standards on safety, quality and efficacy.</p><p>The decision to accept a particular vaccine is ultimately for individual European Union Member States. The EU has published a list of vaccines it sees as equivalent to those authorised by the European Medicines Agency for the purposes of travel includes all vaccines administered in the UK, including all batches of AstraZeneca COVID-19 vaccines.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 14/09/2021 15:34:16 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1438 label Biography information for Mr Kevan Jones

1353505

registered interest
date	07/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans his Department has for a covid-19 vaccine booster campaign in autumn 2021.
tabling member constituency	Central Ayrshire
tabling member printed	Dr Philippa Whitford
uin	44364
answer	answer is ministerial correction date of answer 10/09/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) published interim advice on a potential Covid-19 booster vaccination programme on 30th June 2021, which can be found at the following link:</p><p><a href="https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022" target="_blank">https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022</a></p><p>The JCVI’s interim advice is that COVID-19 boosters should first be offered to the most vulnerable. The JCVI advises a two staged approach, with individuals in Stage 1 offered a COVID-19 booster vaccine, and flu vaccine, as soon as possible from September, and individuals in Stage 2 offered a COVID-19 booster vaccine as soon as practicable after Stage 1, with equal emphasis on deployment of the flu vaccine where eligible.</p><p>Final decisions on the timing and scope and cohort eligibility, including the groups listed above, of any COVID-19 vaccine booster programme will be confirmed once the JCVI have provided their final advice, alongside considerations related to COVID-19 vaccine supply and approvals by the Medicines and Healthcare products Regulatory Agency.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 10/09/2021 13:46:11 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4385 label Biography information for Dr Philippa Whitford

1353507

registered interest
date	07/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department has taken to ensure long term monitoring of immunity in people who have received different covid-19 vaccines for each dose.
tabling member constituency	Central Ayrshire
tabling member printed	Dr Philippa Whitford
uin	44365
answer	answer is ministerial correction date of answer 10/09/2021 answer text <p>The National Institute for Health Research has commissioned the National Immunisation Schedule Evaluation Consortium to undertake the Com-CoV trial. This trial is gathering data on the long-term immune response of using different COVID-19 vaccines for the first and second dose.</p><p>Public Health England has also undertaken follow up on people given mixed schedules as part of routine care to monitor self-reported side effects and antibody response. The antibody results will be published in due course.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 10/09/2021 09:07:39 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4385 label Biography information for Dr Philippa Whitford